Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

Similar articles for PubMed (Select 12150915)

1.
2.

Silencing of tuberin enhances photoreceptor survival and function in a preclinical model of retinitis pigmentosa (an american ophthalmological society thesis).

Tsang SH, Chan L, Tsai YT, Wu WH, Hsu CW, Yang J, Tosi J, Wert KJ, Davis RJ, Mahajan VB.

Trans Am Ophthalmol Soc. 2014 Jul;112:103-15.

3.

SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer.

Gasser JA, Inuzuka H, Lau AW, Wei W, Beroukhim R, Toker A.

Mol Cell. 2014 Nov 20;56(4):595-607. doi: 10.1016/j.molcel.2014.09.023. Epub 2014 Oct 30.

PMID:
25458846
4.

Tuberin-deficiency downregulates N-cadherin and upregulates vimentin in kidney tumor of TSC patients.

Liang S, Salas T, Gencaslan E, Li B, Habib SL.

Oncotarget. 2014 Aug 30;5(16):6936-46.

5.

BRD7, a tumor suppressor, interacts with p85α and regulates PI3K activity.

Chiu YH, Lee JY, Cantley LC.

Mol Cell. 2014 Apr 10;54(1):193-202. doi: 10.1016/j.molcel.2014.02.016. Epub 2014 Mar 20.

6.

Inactivating CUX1 mutations promote tumorigenesis.

Wong CC, Martincorena I, Rust AG, Rashid M, Alifrangis C, Alexandrov LB, Tiffen JC, Kober C; Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium, Green AR, Massie CE, Nangalia J, Lempidaki S, Döhner H, Döhner K, Bray SJ, McDermott U, Papaemmanuil E, Campbell PJ, Adams DJ.

Nat Genet. 2014 Jan;46(1):33-8. doi: 10.1038/ng.2846. Epub 2013 Dec 8.

7.

Class I PI 3-kinases signaling in platelet activation and thrombosis: PDK1/Akt/GSK3 axis and impact of PTEN and SHIP1.

Laurent PA, Severin S, Gratacap MP, Payrastre B.

Adv Biol Regul. 2014 Jan;54:162-74. doi: 10.1016/j.jbior.2013.09.006. Epub 2013 Sep 18. Review.

PMID:
24095650
8.

Research resource: identification of novel growth hormone-regulated phosphorylation sites by quantitative phosphoproteomics.

Ray BN, Kweon HK, Argetsinger LS, Fingar DC, Andrews PC, Carter-Su C.

Mol Endocrinol. 2012 Jun;26(6):1056-73. doi: 10.1210/me.2011-1258. Epub 2012 May 8.

9.

Calpain interacts with class IA phosphoinositide 3-kinases regulating their stability and signaling activity.

Beltran L, Chaussade C, Vanhaesebroeck B, Cutillas PR.

Proc Natl Acad Sci U S A. 2011 Sep 27;108(39):16217-22. doi: 10.1073/pnas.1107692108. Epub 2011 Sep 19.

10.

A novel Akt3 mutation associated with enhanced kinase activity and seizure susceptibility in mice.

Tokuda S, Mahaffey CL, Monks B, Faulkner CR, Birnbaum MJ, Danzer SC, Frankel WN.

Hum Mol Genet. 2011 Mar 1;20(5):988-99. doi: 10.1093/hmg/ddq544. Epub 2010 Dec 15.

11.

Role of tuberin in neuronal degeneration.

Habib SL, Michel D, Masliah E, Thomas B, Ko HS, Dawson TM, Abboud H, Clark RA, Imam SZ.

Neurochem Res. 2008 Jun;33(6):1113-6. doi: 10.1007/s11064-007-9558-8. Epub 2008 Mar 5.

12.

Pam (Protein associated with Myc) functions as an E3 ubiquitin ligase and regulates TSC/mTOR signaling.

Han S, Witt RM, Santos TM, Polizzano C, Sabatini BL, Ramesh V.

Cell Signal. 2008 Jun;20(6):1084-91. doi: 10.1016/j.cellsig.2008.01.020. Epub 2008 Feb 1.

13.

PtdIns5P activates the host cell PI3-kinase/Akt pathway during Shigella flexneri infection.

Pendaries C, Tronchère H, Arbibe L, Mounier J, Gozani O, Cantley L, Fry MJ, Gaits-Iacovoni F, Sansonetti PJ, Payrastre B.

EMBO J. 2006 Mar 8;25(5):1024-34. Epub 2006 Feb 16.

14.

The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells.

She QB, Solit DB, Ye Q, O'Reilly KE, Lobo J, Rosen N.

Cancer Cell. 2005 Oct;8(4):287-97.

15.

Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2.

Manning BD, Logsdon MN, Lipovsky AI, Abbott D, Kwiatkowski DJ, Cantley LC.

Genes Dev. 2005 Aug 1;19(15):1773-8. Epub 2005 Jul 18.

16.

mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.

Hu X, Pandolfi PP, Li Y, Koutcher JA, Rosenblum M, Holland EC.

Neoplasia. 2005 Apr;7(4):356-68.

17.

Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast.

Rodríguez-Escudero I, Roelants FM, Thorner J, Nombela C, Molina M, Cid VJ.

Biochem J. 2005 Sep 1;390(Pt 2):613-23.

18.

Human and mouse mesotheliomas exhibit elevated AKT/PKB activity, which can be targeted pharmacologically to inhibit tumor cell growth.

Altomare DA, You H, Xiao GH, Ramos-Nino ME, Skele KL, De Rienzo A, Jhanwar SC, Mossman BT, Kane AB, Testa JR.

Oncogene. 2005 Sep 8;24(40):6080-9.

PMID:
15897870
19.

PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes.

Tang X, Powelka AM, Soriano NA, Czech MP, Guilherme A.

J Biol Chem. 2005 Jun 10;280(23):22523-9. Epub 2005 Apr 11.

20.

Identification of WNK1 as a substrate of Akt/protein kinase B and a negative regulator of insulin-stimulated mitogenesis in 3T3-L1 cells.

Jiang ZY, Zhou QL, Holik J, Patel S, Leszyk J, Coleman K, Chouinard M, Czech MP.

J Biol Chem. 2005 Jun 3;280(22):21622-8. Epub 2005 Mar 30.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk